ArticleFrontiers in molecular biosciences2021

LBX2-AS1 as a Novel Diagnostic Biomarker and Therapeutic Target Facilitates Multiple Myeloma Progression by Enhancing mRNA Stability of LBX2.

Haipeng Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.